Beyond Dupixent®
We’re building on the success of Dupixent® in atopic dermatitis and asthma, developing new solutions for people with debilitating immuno-dermatological, rheumatic, respiratory, and gastrointestinal diseases.
![Automatisation lab. mRNA equipment - Marcy l'Etoile, France](/optim/dotcom/pages/images/partnering/partnering-focus-areas/immunology-partnerships/scaling-up-innovation_20240223112519.jpg?size=large)
Scaling up Innovation
We partner with companies that bring cutting-edge technologies and transformative assets in immuno-inflammation. We bring expertise in biological pathways, research-enabling technologies, proven precision-medicine approaches to clinical development, and robust commercial organization.
Partnering Success Stories
![](/optim/dotcom/pages/images/partnering/partnering-focus-areas/partnering-focus-areas-logos/partnering-logo-regeneron_20240223112519.jpg?size=large)
Regeneron
This global collaboration produced Dupixent®, a novel biologic approved for atopic dermatitis, severe asthma, and eosinophilic esophagitis, and in development for a range of additional potential indications.
![](/optim/dotcom/pages/images/partnering/partnering-focus-areas/partnering-focus-areas-logos/partnering-logo-kymera_20240223112519.jpg?size=large)
Kymera
In partnership with Kymera, we develop and commercialize first-in-class protein degrader therapies that target IRAK4 in patients with immuno-inflammatory diseases.
![](/optim/dotcom/pages/images/partnering/partnering-focus-areas/partnering-focus-areas-logos/partnering-logo-immunext_20240223112519.jpg?size=large)
ImmuNext
We’re working on a CD40L monoclonal antibody (INX-021) initially developed by ImmuNext, as a treatment for autoimmune diseases including lupus and multiple sclerosis.
Your Partnering Leads in Immunology
For more information, contact our Business development team
![Mark Dowling](/optim/dotcom/pages/images/partnering/partnering-mark-dowling_20240223112519.jpg?size=orig)
Mark Dowling
Head of External Innovation, Immunology
![Ulrich Wendt](/optim/dotcom/pages/images/partnering/partnering-uli-wendt_20240223112519.jpg?size=orig)
Ulrich Wendt
Global Head of Business Development, Immunology